Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology

BACKGROUND: No head-to-head clinical trials have been published comparing guanfacine extended release (GXR) and atomoxetine (ATX): two nonstimulants approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). However, other study designs or methods could be used to indirectly comp...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Sikirica, Vanja, Findling, Robert L., Signorovitch, James, Erder, M. Haim, Dammerman, Ryan, Hodgkins, Paul, Lu, Mei, Xie, Jipan, Wu, Eric Q.
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer International Publishing 2013
נושאים:
Original Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3824845/
https://ncbi.nlm.nih.gov/pubmed/23975660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-013-0102-x
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים